Arena Pharmaceuticals News
Most Popular Arena Pharmaceuticals Story
Arena gets 10/22 PDUFA date for lorcaserin
Arena Pharmaceuticals should know by October 22 if its closely-watched obesity drug--lorcaserin--will win approval by the FDA. The drug is widely viewed as a likely blockbuster if it breaks into the... Read more...
Latest Headlines
- March 12, 2010
- February 26, 2010
- December 24, 2009
- October 27, 2009
- October 19, 2009
- September 22, 2009
- September 18, 2009
- June 17, 2009
- June 9, 2009
- April 24, 2009
- March 30, 2009
- March 24, 2009
- December 10, 2008
- July 29, 2008
- June 20, 2008
- March 17, 2008
- November 2, 2007
- September 25, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
